Q3 2022 Holdings
Filed 2022-11-14 | 104 holdings | $38.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $8.9M | 317,476 | 23.2% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $6.0M | 472,054 | 15.7% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $5.3M | 325,000 | 13.9% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $3.8M | 3,178,825 | 9.9% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $3.5M | 350,000 | 9.1% |
| ARK ETF TR(ARKG) | GENOMIC REV ETF | 00214Q302 | $3.2M | 96,462 | 8.3% |
| Biogen Inc(BIIB) | COM | 09062X103 | $2.9M | 10,962 | 7.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $2.4M | 162,766 | 6.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $560.0K | 2,800 | 1.5% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $556.0K | 260,087 | 1.4% |
| Anebulo Pharmaceuticals Inc(ANEB) | COM | 034569103 | $437.0K | 156,203 | 1.1% |
| ARK ETF TR(ARKK) | INNOVATION ETF | 00214Q104 | $171.0K | 4,519 | 0.4% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $109.0K | 168,623 | 0.3% |
| Relmada Therapeutics Inc(RLMD)Put | COM | 75955J402 | $28.7K | 775,300 | 0.1% |
| Relmada Therapeutics Inc(RLMD)Call | COM | 75955J402 | $28.7K | 775,300 | 0.1% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $21.4K | 60,000 | 0.1% |
| Seagen Inc(SGENUSD)Call | COM | 81181C104 | $20.5K | 150,000 | 0.1% |
| Biogen Inc(BIIB)Call | COM | 09062X103 | $18.8K | 70,500 | 0.0% |
| Axsome Therapeutics Inc(AXSM)Put | COM | 05464T104 | $18.2K | 407,600 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $17.6K | 978,783 | 0.0% |
| Dice Therapeutics IncCall | COM | 23345J104 | $15.2K | 748,900 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $14.3K | 2,131,147 | 0.0% |
| Biogen Inc(BIIB)Put | COM | 09062X103 | $14.2K | 53,200 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $13.6K | 231,181 | 0.0% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $11.9K | 150,000 | 0.0% |
| Altimmune Inc(ALT)Call | COM NEW | 02155H200 | $10.8K | 842,600 | 0.0% |
| Prometheus Biosciences IncCall | COM | 74349U108 | $10.5K | 178,000 | 0.0% |
| Dice Therapeutics IncPut | COM | 23345J104 | $10.2K | 504,100 | 0.0% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $9.4K | 85,200 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $9.1K | 492,275 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $9.0K | 850,134 | 0.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $7.9K | 855,616 | 0.0% |
| Iveric BIO Inc(OPHTEUR)Call | COM | 46583P102 | $7.9K | 437,900 | 0.0% |
| Tricida Inc(1T7)Put | COM | 89610F101 | $7.6K | 727,900 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $7.3K | 610,407 | 0.0% |
| Amylyx Pharmaceuticals Inc(AMLX)Call | COM | 03237H101 | $7.0K | 250,000 | 0.0% |
| Krystal Biotech Inc(KRYS)Put | COM | 501147102 | $6.6K | 95,200 | 0.0% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $6.3K | 699,440 | 0.0% |
| Gossamer BIO Inc(GOSS)Call | COM | 38341P102 | $6.3K | 526,600 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $6.3K | 728,586 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $6.2K | 157,805 | 0.0% |
| Tricida Inc(1T7)Call | COM | 89610F101 | $6.1K | 577,600 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $5.8K | 160,486 | 0.0% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $5.3K | 904,119 | 0.0% |
| Horizon Therapeutics PUB LCall | SHS | G46188101 | $5.3K | 85,100 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $5.0K | 178,100 | 0.0% |
| Stoke Therapeutics Inc(STOK)Put | COM | 86150R107 | $4.7K | 368,700 | 0.0% |
| Tracon Pharmaceuticals Inc | COM NEW | 89237H209 | $4.6K | 2,765,530 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $4.6K | 74,219 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $4.5K | 811,700 | 0.0% |